Новости/Reuters/EMA committee recommends approval for injectable version of Merck's KeytrudaEMA committee recommends approval for injectable version of Merck's KeytrudaRefinitivЗаймёт меньше минутыMRKMerck MRK said on Friday the European Medicines Agency's committee has recommended the approval for a new formulation of its MRK blockbuster cancer therapy Keytruda that can be administered under the skin.ReutersАкции США© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.htmlПоказать большеЧтобы прочитать эту статью, зарегистрируйтесь на TradingView — это бесплатноПопробовать
